Cargando…
Upregulation of lncRNA CASC2 Suppresses Cell Proliferation and Metastasis of Breast Cancer via Inactivation of the TGF-β Signaling Pathway
Breast cancer is one of the major malignancies with a mounting mortality rate in the world. Long noncoding RNA (lncRNA) cancer susceptibility candidate 2 (CASC2) has been identified to regulate the initiation and progression of multiple tumorous diseases according to previous studies. However, its b...
Autores principales: | Zhang, Yang, Zhu, Min, Sun, Yuanbo, Li, Wenyuan, Wang, Ying, Yu, Weiguang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cognizant Communication Corporation
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7848420/ https://www.ncbi.nlm.nih.gov/pubmed/29523222 http://dx.doi.org/10.3727/096504018X15199531937158 |
Ejemplares similares
-
lncRNA CASC9 sponges miR-758-3p to promote proliferation and EMT in bladder cancer by upregulating TGF-β2
por: Zhang, Zeng, et al.
Publicado: (2021) -
LncRNA CASC 2 is upregulated in aphthous stomatitis and predicts the recurrence
por: Lu, Jiaping, et al.
Publicado: (2020) -
LncRNA CASC9 interacts with CPSF3 to regulate TGF-β signaling in colorectal cancer
por: Luo, Kaili, et al.
Publicado: (2019) -
LncRNA CASC11 is upregulated in postmenopausal osteoporosis and is correlated with TNF-α
por: Yu, Haotao, et al.
Publicado: (2019) -
Down-regulation of lncRNA CASC2 promotes cell proliferation and metastasis of bladder cancer by activation of the Wnt/β-catenin signaling pathway
por: Pei, Zhijun, et al.
Publicado: (2017)